Total item
Cart Subtotal
$0.00 Biological Activity
AT7519 is an inhibitor of multiple cyclin-dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation.
Targets
| Target | Value |
|---|---|
| CDK9/CyclinT | IC50: <10nM |
| CDK5/p35 | IC50: 13nM |
| CDK2/CyclinA | IC50: 47nM |
| GSK-3β | IC50: 89nM |
| CDK4/CyclinD1 | IC50: 100nM |
| CDK6/CyclinD3 | IC50: 170nM |
| CDK1/CyclinB | IC50: 210nM |
| CDK3/CyclinE | IC50: 360nM |
| PI3Kβ | IC50: >1μM |
| PLK3 | IC50: >1μM |
| RET | IC50: >1μM |
| SGK | IC50: >1μM |
| TrkB | IC50: >1μM |
| JAK2 | IC50: >1μM |
| CDK7/CyclinH/MAT1 | IC50: 2.4μM |
| SAPK2A(p38α) | IC50: >10μM |
| p70S6K | IC50: >10μM |
| PDGFR | IC50: >10μM |
| PDK-1 | IC50: >10μM |
| PKBβ | IC50: >10μM |
| VEGFR1 | IC50: >10μM |
| AuroraA | IC50: >10μM |
| c-Abl | IC50: >10μM |
| c-Src | IC50: >10μM |
| Chk1 | IC50: >10μM |
| EGFR | IC50: >10μM |
| FGFR3 | IC50: >10μM |
| IR | IC50: >10μM |
| JNK2 | IC50: >10μM |
| MAPK1 | IC50: >10μM |
| MEK1 | IC50: >10μM |
| Met | IC50: >10μM |
| In vitro (25°C) | DMSO | 9 mg/mL (23.54 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 2% DMSO+30% PEG 300+2% Tween 80+ddH2O | 1 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 26.16 mL | 130.82 mL | 261.64 mL |
| 0.5 mM | 5.23 mL | 26.16 mL | 52.33 mL |
| 1 mM | 2.62 mL | 13.08 mL | 26.16 mL |
| 5 mM | 0.52 mL | 2.62 mL | 5.23 mL |
*The above data is based on the productmolecular weight 382.2. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A10093 |
|---|---|
| Actions | Inhibitor |
| CAS No. | 844442-38-2 |
| Formula | C16H17Cl2N5O2 |
| M. Wt | 382.2 |
| Purity | >98% |
| Synonyms | AT-7519 |
| SMILES | C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
Product Tags
Product Questions
Product Questions
No Questions
You may also be interested in the following product(s)
Flavopiridol (Alvocidib)
Flavopiridol (Alvocidib) is a cyclin-dependent kinase inhibitor under clinical development for the treatment of chronic lymphocytic leukemia…
CGP60474
CGP60474 is a potent inhibitor of cyclin-dependent kinase (CDK).
AT7519 trifluoroacetate
AT7519 trifluoroacetate is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM, less potent to CDK3 and little active to CD…
JNJ-7706621
JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing >6-fold selectivity for CDK1/2 than C…
LEE011 (Ribociclib)
LEE011 is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with p…
Kenpaullone
Kenpaullone is a potent inhibitor of CDK1/cyclin B (IC₅₀ = 400 nM), CDK2/cyclin A (IC₅₀ = 680nM) , CDK5 (IC₅₀ = 850nM) and with …
Purvalanol A
Purvalanol A is a potent, cell-permeable cyclin-dependent protein kinase (cdk) inhibitor. IC50 values are 4, 70, 35, 850 and 75 nM for cdc2/…
BS-181 HCl
BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.
Keywords:buy AT7519 | AT7519 Supplier | purchase | cost | manufacturer | order | distributor | buy 844442-38-2| 844442-38-2 Supplier | purchase 844442-38-2 | 844442-38-2 cost | 844442-38-2 manufacturer | order 844442-38-2 | 844442-38-2 distributor
Adooq Quality Guarantee
We promise all products perform as described.